Advertisement
Loading...

Revive Therapeutics Ltd.

RVVTF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.03
$0.004(17.92%)
U.S. Market opens in 44h 15m
Advertisement

Revive Therapeutics Ltd. (RVVTF) Stock Overview

Explore Revive Therapeutics Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap12.3M
P/E Ratio-1.51
EPS (TTM)$-0.02
ROE9.00%
Fundamental Analysis

AI Price Forecasts

1 Month$0.03
3 Months$0.02
1 Year Target$0.00

RVVTF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Revive Therapeutics Ltd. (RVVTF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.81, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.51 and a market capitalization of 12.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
12.08%
5-Day Change
19.03%
1-Month Change
-8.81%
3-Month Change
205.68%
6-Month Change
158.65%
Year-to-Date (YTD) Change
226.06%
1-Year Change
34.50%
3-Year Change
-39.69%
5-Year Change
-92.92%
All-Time (Max) Change
-94.88%

Contact Information

https://www.revivethera.com
888-901-0036
The Canadian Venture Building, Toronto, ON, M5C 1P1

Company Facts

3 Employees
IPO DateDec 2, 2015
CountryCA
Actively Trading

Frequently Asked Questions